Can heated chemo during surgery help older women with ovarian cancer?

NCT ID NCT07733505

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study tests whether giving heated chemotherapy directly into the abdomen during surgery is safe for women aged 70 and older with advanced ovarian cancer. The treatment, called NIPEC with carboplatin, is delivered at normal body temperature for 90 minutes right after the surgeon removes visible tumors. Researchers will closely monitor complications, recovery, and quality of life to see if this approach allows frail patients to complete standard chemotherapy afterward.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Normothermic intraperitoneal chemotherapy with carboplatin
What this could lead to
If safe and feasible, this approach could offer a treatment option for elderly or frail ovarian cancer patients who may not tolerate standard therapy.
What could go wrong
This is a very small early-phase study with only 10 participants, so results may not apply broadly. The chemotherapy is given directly into the abdomen, which carries risks of infection, organ damage, and side effects from carboplatin.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Odense University Hospital

    RECRUITING

    Odense, 5000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.